Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CD96 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RAC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAP2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIF16B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GUCY1A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ST3GAL6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR5I1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADRA1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIF25-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
KIF3C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BEND4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCDH11Y - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FCGR1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PMP22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRGPRX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on